SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001571049-17-008750
Filing Date
2017-12-21
Accepted
2017-12-21 15:10:03
Documents
11

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS tv481346-424b1.htm 424B1 1763026
2 GRAPHIC lg_cuebiopharma.jpg GRAPHIC 162795
3 GRAPHIC t1702624_img-apc.jpg GRAPHIC 89460
4 GRAPHIC t1702624_img-tumor.jpg GRAPHIC 63049
5 GRAPHIC t1702624_img-indications.jpg GRAPHIC 69219
6 GRAPHIC t1702624_img-frameworks.jpg GRAPHIC 75019
7 GRAPHIC t1702624_line-donor.jpg GRAPHIC 230313
8 GRAPHIC t1702624_bar-expansion.jpg GRAPHIC 83822
9 GRAPHIC t1702624_img-stimulation.jpg GRAPHIC 141324
10 GRAPHIC t1702624_img-activated.jpg GRAPHIC 517499
11 GRAPHIC t1702624_img-interaction.jpg GRAPHIC 130393
  Complete submission text file 0001571049-17-008750.txt   3867925
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-220550 | Film No.: 171269234
SIC: 2834 Pharmaceutical Preparations